GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of unpopular opinion: most of what gets said here about API source is guesswork — 50 comments in the full submission. View in context.
3.6k
c/compounding·submitted 1 year ago by u/hugo_bergstrom

unpopular opinion: most of what gets said here about API source is guesswork

Discussionbranch of 6 comments

Something I keep coming back to: unpopular opinion: most of what gets said here about API source is guesswork. The intake asked me three questions and none of them were about my history. That told me everything I needed to know about the model. Switched between two compounded preparations and the concentration on the…

Read the full submission and all 50 comments →

This branch

6 comments, started 1 year ago
u/vikram_mbeki150 points·1 year ago

Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.

replysharereportpermalink
u/solene_eriksen120 points·1 year ago

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board. Different mechanisms.

replysharereportpermalink
u/receptor_bias_rick93 points·1 year ago·edited

Small fix — 503B facilities register with the regulator; 503A pharmacies are licensed by the state board.

This is the distinction the whole board runs on. Everything else follows from it.

replysharereportpermalink
u/slow_logbook30 points·1 year ago

the API source is the question nobody asks and everybody should

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →